Note: Ingredients listed on restricted chemical lists
EC/CAS
200-652-8/67-43-6
Name of the chemical
N-Carboxymethyliminobis(ethylennitrilo)-tetraessigsäure (2022/692)
Concentration
≥ 3 %
General Information
Version
6.0 en
Revision date
2026-03-18
Product name
Diethylene triamine pentaacetic acid ≥99 %, for synthesis
Product Synonyms
DTPA
CAS No.
67-43-6
REACH No
01-2119497281-34-xxxx
1.2.2. Uses advised against
Do not use for products which come into contact with foodstuffs. Do not use for private purposes (household). Food, drink and animal feeding- stuffs. Authorisations and/or restrictions on use see section 15 "restrictions"
Icons in SDS
Company Information
company name
Carl Roth GmbH + Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
sicherheit@carlroth.de
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H319, H332, H360Df, H373
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No 1272/2008 [CLP Classification of the substance or mixture
Hazard categories
Cat- Hazard class and Hazard egory category statement 3.1I Acute toxicity (inhal.) Acute Tox. 4 H332 3.3 Serious eye damage/eye irritation Eye Irrit. 2 H319 3.7 Reproductive toxicity 1B Repr. 1B H360Df 3.9 Specific target organ toxicity - repeated exposure STOT RE 2 H373 For full text of abbreviations: see SECTION 16
Most important adverse effects
Delayed or immediate effects can be expected after short or long-term exposure
Signal word
Danger Danger Not required
Hazard pictograms
GHS07, GHS08 H360Df May damage the unborn child. Suspected of damaging fertility. P280 Wear protective gloves/protective clothing/eye protection/face protection. Labelling of packages where the contents do not exceed 10 ml
Hazard statements
H319 Causes serious eye irritation H332 Harmful if inhaled H360Df May damage the unborn child. Suspected of damaging fertility H373 May cause damage to organs (respiratory tract) through prolonged or repeated exposure (if inhaled) Not required
Prevention
P261 Avoid breathing mist/vapours/spray P280 Wear protective gloves/protective clothing/eye protection/face protection
Response
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing For professional users only Labelling of packages where the contents do not exceed 125 ml
Precautionary statements
Not required
Results of PBT and vPvB assessment
According to the results of its assessment, this substance is not a PBT or a vPvB. Endocrine disrupting properties Does not contain an endocrine disruptor (ED) at a concentration of ≥ 0,1%.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 (CLP) Section Hazard class Cat- Hazard class and Hazard egory category statement 3.1I Acute toxicity (inhal.) 4 Acute Tox. 4 H332 3.3 Serious eye damage/eye irritation 2 Eye Irrit. 2 H319 3.7 Reproductive toxicity 1B Repr. 1B H360Df 3.9 Specific target organ toxicity - repeated exposure 2 STOT RE 2 H373 For full text of abbreviations: see SECTION 16 The most important adverse physicochemical, human health and environmental effects Delayed or immediate effects can be expected after short or long-term exposure.
